256 related articles for article (PubMed ID: 28161890)
21. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
[TBL] [Abstract][Full Text] [Related]
22. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1.
McArthur JR; Motin L; Gleeson EC; Spiller S; Lewis RJ; Duggan PJ; Tuck KL; Adams DJ
Br J Pharmacol; 2018 Jun; 175(12):2284-2295. PubMed ID: 28608537
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.
Moutal A; Yang X; Li W; Gilbraith KB; Luo S; Cai S; François-Moutal L; Chew LA; Yeon SK; Bellampalli SS; Qu C; Xie JY; Ibrahim MM; Khanna M; Park KD; Porreca F; Khanna R
Pain; 2017 Dec; 158(12):2301-2319. PubMed ID: 28809766
[TBL] [Abstract][Full Text] [Related]
26. Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain.
Loya-Lopez SI; Allen HN; Duran P; Calderon-Rivera A; Gomez K; Kumar U; Shields R; Zeng R; Dwivedi A; Saurabh S; Korczeniewska OA; Khanna R
Pain; 2024 Mar; 165(3):573-588. PubMed ID: 37751532
[TBL] [Abstract][Full Text] [Related]
27. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
[TBL] [Abstract][Full Text] [Related]
28. Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.
Brittain JM; Pan R; You H; Brustovetsky T; Brustovetsky N; Zamponi GW; Lee WH; Khanna R
Channels (Austin); 2012; 6(1):52-9. PubMed ID: 22373559
[TBL] [Abstract][Full Text] [Related]
29. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.
Buchta WC; Moutal A; Hines B; Garcia-Keller C; Smith ACW; Kalivas P; Khanna R; Riegel AC
Mol Neurobiol; 2020 Jan; 57(1):346-357. PubMed ID: 31359322
[TBL] [Abstract][Full Text] [Related]
30. Injury-induced maladaptation and dysregulation of calcium channel α
Gong N; Park J; Luo ZD
Br J Pharmacol; 2018 Jun; 175(12):2231-2243. PubMed ID: 28646556
[TBL] [Abstract][Full Text] [Related]
31. Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.
Roca-Lapirot O; Radwani H; Aby F; Nagy F; Landry M; Fossat P
Br J Pharmacol; 2018 Jun; 175(12):2362-2374. PubMed ID: 28214378
[TBL] [Abstract][Full Text] [Related]
32. The natural product argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels.
Duran P; Loya-López S; Ran D; Tang C; Calderon-Rivera A; Gomez K; Stratton HJ; Huang S; Xu YM; Wijeratne EMK; Perez-Miller S; Shan Z; Cai S; Gabrielsen AT; Dorame A; Masterson KA; Alsbiei O; Madura CL; Luo G; Moutal A; Streicher J; Zamponi GW; Gunatilaka AAL; Khanna R
Br J Pharmacol; 2023 May; 180(9):1267-1285. PubMed ID: 36245395
[TBL] [Abstract][Full Text] [Related]
33. Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.
Ju W; Li Q; Allette YM; Ripsch MS; White FA; Khanna R
J Neurochem; 2013 Mar; 124(6):869-79. PubMed ID: 23106100
[TBL] [Abstract][Full Text] [Related]
34. Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.
Moutal A; François-Moutal L; Brittain JM; Khanna M; Khanna R
Front Cell Neurosci; 2014; 8():471. PubMed ID: 25674050
[TBL] [Abstract][Full Text] [Related]
35. TNF-α mediated upregulation of Na
de Macedo FHP; Aires RD; Fonseca EG; Ferreira RCM; Machado DPD; Chen L; Zhang FX; Souza IA; Lemos VS; Romero TRL; Moutal A; Khanna R; Zamponi GW; Cruz JS
Mol Brain; 2019 Dec; 12(1):117. PubMed ID: 31888677
[TBL] [Abstract][Full Text] [Related]
36. Non-SUMOylated CRMP2 decreases Na
Gomez K; Ran D; Madura CL; Moutal A; Khanna R
Mol Brain; 2021 Jan; 14(1):20. PubMed ID: 33478555
[TBL] [Abstract][Full Text] [Related]
37. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.
François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R
Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699
[TBL] [Abstract][Full Text] [Related]
38. Sodium channels and pain: from toxins to therapies.
Cardoso FC; Lewis RJ
Br J Pharmacol; 2018 Jun; 175(12):2138-2157. PubMed ID: 28749537
[TBL] [Abstract][Full Text] [Related]
39. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.
Moutal A; Ji Y; Bellampalli SS; Khanna R
Mol Brain; 2020 Jun; 13(1):97. PubMed ID: 32571373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
